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Background. The aim of this study is to assess the impacts of “Maras powder” and cigarette smoking on the parameters of the
humoral immune system. Material and Methods. One hundred seventy seven subjects were included in the study. The IgA, IgG,
IgM, C3 and C4 levels were detected via nephelometric method. Results. In 1.4% of the control group IgM levels were below
normal where it was 10.8% and 18.6% in Maras powder group and in cigarette smoking group respectively. The IgM levels of both
groups were signiﬁcantly lower compared to the control group (P<. 05). Nonetheless, the IgE levels of Maras powder group and
smoking group were found to be remarkably higher compared to the control group (P<. 01). Conclusion. Eﬀects of Maras powder
on humoral immune response were found to be similar to that of smoking.
Copyright © 2006 Murat Aral et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BACKGROUND
In Turkey a kind of smokeless tobacco called Maras pow-
der has a lot of addicts in the city of Kahramanmaras ¸a n d
its surroundings [1–3]. The leaves of Nicotina rustica L.
are powdered, mixed, crushed with the ash obtained from
the oak, walnut tree, or vine stick in the proportion of
1/2 or 1/3, and humidiﬁed a little before it is used. It is
known that the ash blended during the preparation stage
of Maras powder eases the absorption of nicotine from the
mouth mucous membrane by making the medium alkaline.
Maras powder is a kind of smokeless tobacco that is used
by the addicts through buccal mucosa instead of cigarette
or in order to give up smoking. On the other hand, it is
more addictive than smoking. Its negative impacts on hu-
man health could not yet be understood fully. A similar
kind of smokeless tobacco used in Sudan is known as Toom-
bak. It is reported that Toombak use may play an impor-
tant role in the etiology of oral squamosus cell carcinoma
of the oral cavity and also may be associated with salivary
gland cancers [4, 5]. Due to the fact that it is taken orally,
it is reported that the cronic stimulation of the lenfoid tis-
sues in oral mucous membrane may be related to the in-
creased gingivitis, leukoplacis, and oral cancer incidence.
Similarly, it is stated that it has a stronger potential of lead-
ing to addiction compared to cigarette smoking because of
its higher nicotine concentration and prolonged mean usage
time [6].
Most of the diseases related to smoking have been known
in detail so far. More than 400000 people die in the USA
because of smoking and the direct expenditures for med-
ical purposes regarding smoking-related morbidity exceed
50 million US dollars. The eﬀect of smoking on the im-
mune system and its parameters is not understood fully
and the data about this is limited and somewhat contra-
dictory. The studies up till now put forth that the im-
munotoxic and genotoxic impacts of cigarette arise from
the particle phase more than the smoke-phase. The par-
ticle phase is composed of thousands of substances, but
mainly nicotine. There are a lot of ﬁndings about the fact
that nicotine is the major immunosuppressive in cigarette
and/or smokeless tobacco. Nicotine causes the secretion
of chatecolamines that have suppressive eﬀects on im-
mune system by inducing ACTH secretion [7]. It is cru-
cial to clarify the relation between tobacco smoking and im-
mune system in order to understand this biological process
fully.
The aim of this study was to determine the eﬀects of
Maras powder use and cigarette smoking on the parameters
of humoral immune response.2 Mediators of Inﬂammation
MATERIALS AND METHODS
The study was conducted between January 2004 and June
2004 in Kahramanmaras Sutcu Imam University, Faculty of
Medicine. All subjects included in the study population were
healthy volunteers recruited from visitors. Informed consent
was obtained from all the subjects participating in the study.
The control group was composed of 33 women (41.1%) and
37 men (52.9%) with no history of smoking or Maras pow-
der usage; the smokers group was composed of 31 women
(42.2%) and 39 men (55.8%); and Maras powder group
was composed of 17 women (45.9%) and 20 men (54.1%).
T h em e a na g e sw e r e3 7 .8 ± 12.5 SD (standard deviation)
(min. 19–max. 73), 37.6 ± 12.0 SD (min. 20–max. 71), and
41.9 ± 10.2 SD in the control, smoking, and Maras powder
groups, respectively. Mean ages and the sex distribution of
the groups were similar (P>. 05). Selection criteria of the in-
dividuals were as follows: cigarette smokers have been smok-
ing a pack of cigarettes (twenty in number), Maras powder
addicts have been using at least 2 packs of Maras powder (a
pack is of 16 ± 3g SD) for at least 5 years and nonpassive
smoking for control and Maras powder users.
The blood samples are collected from each subject by
venipuncture of the cubital veins before labour and frozen
at −20◦C after aliquoting their sera until they are stud-
ied. Blood samples were analyzed for concentrations of the
humoral immune system parameters (IgE, IgM, IgG, IgA,
C3, and C4) using nephelometry (Dade Behring, Marburg
GmbH, Germany). The normal values of humoral immune
system parameters were accepted as 0.70–4.00g/L for IgA,
7.0–16.0g/L for IgG, 0.4–2.3g/L for IgM, 0–100IU/mL for
IgE, 0.90–1.80g/L for C3, and 0.10–0.40g/L for C4. The val-
ues under these ranges were deﬁned as “low” (there is no
“low” value for IgE since its range starts from 0unIU/mL),
and over these ranges as “high.”
Data were expressed as mean values ± SD, median and
range, or as number of subjects and percentages. Either
nonparametric or parametric (if data was normally dis-
tributed) tests were used for statistical analyses. ANOVA
and Kruskal-Wallis variance analysis (followed by post-hoc
Mann-Whitney U test where needed) were used for compar-
ison of numerical data. Chi-square tests were performed on
categorical data. P values <. 05 were considered statistically
signiﬁcant. Analyses were performed by using SPSS software,
version 9.05 for Windows (SPSS Inc., Chicago, Ill).
RESULTS
Comparisonofhumoralimmunesystemparametersinstudy
groups were shown in Table 1. No statistically signiﬁcant dif-
ference was detected among the parameters except for IgE
(P>. 05). IgE values of Maras powder and smoking groups
were signiﬁcantly higher than that of the control group (P<
.05). Furthermore, the distribution of subjects according to
ranges of humoral immune system parameters was com-
pared (Table 2). For this purpose, data was classiﬁed as low,
normal, and high for each parameter. The distribution of
normal values was similar for each parameter except IgM
and IgE. In control group 1.4% of the subjects had IgM val-
ues below normal where it was 18.6% and 10.8% in smok-
ing and Maras powder groups, respectively (P<. 05). Af-
ter chi-square analysis, it was seen that IgE values above the
normal had been similar in the smoking and Maras pow-
der groups and signiﬁcantly higher compared to the control
group (P<0.01).
DISCUSSION
It was stated that using tobacco aﬀects both the cellular and
humoral immunity negatively in various ways. Nevertheless,
the level of the negative eﬀects could not yet be explained
clearly. In a number of studies carried out for ﬁnding out the
possible eﬀects of cigarette smoke on lymphocytes, a leuko-
cytosis accompanying the increase in all lymphocyte popula-
tions is mentioned. The relation between cigarette smoking
and eﬀects of cigarette smoke on in vitro lymphocyte func-
tions is disputatious. Some authors reported that there had
been signiﬁcant reductions in the proliferative response of
lymphocytes to T cell mitogens. On the other hand, some
others reported that there had been no signiﬁcant diﬀer-
ence in terms of this response between smokers and non-
smokers. Besides, it was stated that these diﬀerences might
have been inﬂuenced by age, sex, dosage, duration of expo-
sure, and ethnic origin [8–15]. Goud et al [6] reported in-
creases in lymphocyte proliferation and polyclonal IgM re-
sponse caused by smokeless tobacco. However, Lindemann
and Park [16] reported that water-soluble smokeless tobacco
extract had anticytolytic and antiproliferative eﬀects on pe-
ripheral lymphocytes. Possible causes for this disagreement
could not be determined. In white subjects, it was shown
that cigarette smoking was closely related to a series of im-
munological deteriorations accompanied by decreases in im-
munoglobulin levels, the number and the functions of NK
(natural killer) cells, and the number of T cell subgroups
[9, 11, 12, 14]. Moszczynski et al [17]h a do b s e r v e dad e -
crease of CD4/CD8 ratio due to the decrease in the serum
concentration of lysozyme and immunoglobulins and a de-
crease in the number of (CD 16+) NK cells particularly in the
addicts who had smoked for more than 10 years and an in-
crease in the number of (CD 8+) cytotoxic T lymphocytes.
It was shown that smoking decreases serum levels of almost
all types of immunoglobulins except IgE (IgE increases) [18–
20]. There are also some articles that defend the idea that it
has no particular eﬀect on immunoglobulin levels [7].
In our study, rates of subjects with a serum IgM level be-
low normal were signiﬁcantly higher in smoking and Maras
powder groups than in control group (P<. 05). However, the
diﬀerences of serum IgM levels between the 3 groups were
not statistically signiﬁcant. This may be interpreted as con-
tradictory. When the data was studied carefully, it was seen
thattheIgMvaluesbelownormalwereveryclosetothelower
limit. As for IgE levels, rates of subjects with values above
normal were signiﬁcantly higher in smoking and Maras pow-
der groups than in control group (P<0.01). Nearly all of the
individuals (86.5%–95.7%) have levels of IgA, IgG, C3, and
C4 within the normal limits.Murat Aral et al 3
Table 1: Comparison of humoral immune system parameters in study groups.
Control (n = 70) Smoking (n = 70) Maras powder (n = 37) P
Mean ± SD Min.–Med.–Max. Mean ± SD Min.–Med.–Max. Mean ± SD Min.–Med.–Max.
IgA (g/L) 2.2 ± 0.9 0.6–2.0–5.7 1.9 ±0.8 0.5–1.8–4.8 2.3 ±0.9 0.3–2.3–4.5 >. 05
IgM (g/L) 1.3 ± 0.5 0.4–1.3–3.2 1.3 ±0.7 0.3–1.2–3.3 1.2 ±0.4 0.5–1.2–2.3 >. 05
IgG (g/L) 11.7 ±2.7 7.9–11.3–20.8 12.9 ±2.3 8.2–12.9–17.8 12.0 ±3.7 6.9–11.8–31.3 >. 05
IgE (IU/mL) 64.6 ± 43.9 18.0–54.0–236.0 127.9 ±76.2 18.6–113.5–290.0 160.5 ±85.9 119.8–172.0–351.0 <. 01∗
C3 (g/L) 1.3 ± 0.3 0.7–1.3–1.9 1.4 ±0.3 0.8–1.4–2.0 1.1 ±0.3 0.4–0.9–1.8 >. 05
C4 (g/L) 0.3 ± 0.0 0.1–0.2–0.6 0.2 ±0.0 0.1–0.2–0.5 0.2 ±0.1 0.1–0.2–0.8 >. 05
∗The diﬀerence arose from control group.
Table 2: Distribution of the humoral immune system parameters with respect to low, normal, and high ranges in study groups.
Low Normal High Total P
n (%) n (%) n (%) n (%)
IgA∗ (g/L) < 0.70 0.70–4.00 > 4.00 — —
Control 1 (1.4) 67 (95.7) 2 (2.9) 70 (100.0) —
Smoking 7 (10.0) 62 (88.6) 1 (1.4) 70 (100.0) —
Maras powder 3 (8.1) 34 (91.9) — 37 (100.0) —
IgM (g/L) < 0.40 .4–2.3 > 2.3——
Control 1 (1.4) 68 (98.6) — 70 (100.0) <. 05∗
Smoking 13 (18.6) 57 (81.4) — 70 (100.0) —
Maras powder 4 (10.8) 33 (89.2) — 37 (100.0) —
IgG∗ (g/L) < 7.07 .0–16.0 > 16.0— —
Control 1 (1.4) 66 (94.3) 3 (4.3) 70 (100.0) —
Smoking — 66 (94.3) 4 (5.7) 70 (100.0) —
Maras powder 1 (2.7) 35 (94.6) 1 (2.7) 37 (100.0) —
IgE (IU/mL) — 0–100.0 > 100.0— —
Control — 53 (75.7) 17 (24.3) 70 (100.0) <. 01∗
Smoking — 25 (35.7) 45 (64.3) 70 (100.0) —
Maras powder — 10 (27.0) 27 (73.0) 37 (100.0) —
C3∗ (g/L) < 0.90 0.90–1.80 > 1.80 —- —
Control — 62 (88.6) 8 (11.4) 70 (100.0) —
Smoking — 65 (92.6) 5 (7.1) 70 (100.0) —
Maras powder 1 (2.7) 32 (86.5) 4 (10.8) 37 (100.0) —
C4∗ (g/L) < 0.10 0.10–0.40 > 0.40 — —
Control (none) — 66 (94.3) 4 (5.7) 70 (100.0) —
Smoking — 67 (95.7) 3 (4.3) 70 (100.0) —
Maras powder 2 (5.4) 33 (89.2) 2 (5.4) 37 (100.0) —
∗Statistical analysis could not be performed due to the limited number of cases.
∗∗The diﬀerence arose from control group.
In some studies it was reported that alcaloid, nitro-
samine, and nicotine contents distinguish between Nico-
tiana rustica L. and Nicotina tobacum L. alcaloid content of
Maras powder (Nicotiana rustica L.) maybe 6–10 times more
than that of Nicotina tobacum L. [21]. It was reported that
tobacco-speciﬁc nitrosamine content of Toombak was one
hundred times more than that of other types of smokeless
tobacco used in Sweden and USA, and Toombak use was de-
scribed as the highest nonoccupational carcinogen exposure
documented [4, 5]. Three times more urinary cotinine levels
were found in Maras powder addicts than in smokers [22].
However, Lindemann et al reported that plasma nicotine lev-
els were found to be similar in smokeless tobacco users and
smokers [23]. Nevertheless, in our study, the eﬀect of Maras
powder on humoral immune response was found to be simi-
lar to that of smoking.
As noted earlier in our study, many of the researchers
stated that smoking aﬀects the immune system and its pa-
rameters negatively at various levels. Nonetheless, the level
o ft h i sn e g a t i v ee ﬀect could not be determined yet eﬀectively4 Mediators of Inﬂammation
and evidently. The information in literature does not show
any coherence at all. We believe that further studies investi-
gating the eﬀects of diﬀerent types of tobacco usage on hu-
moral immune system parameters are needed.
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